
Amgen deal for Onyx possible within week: sources
NEW YORK (Reuters) - Onyx Pharmaceuticals Inc is close to selling itself to larger rival Amgen Inc as the cancer drugmaker's high stock price has discouraged other companies from making...
eNewspaper
Trending:









